1 in 25 Americans lives with a serious mental illness, and the majority of patients are re-hospitalized due to poor medication adherence. Otsuka challenged convention by developing the world’s first digital medicine system to help overcome these issues. This innovative offering uses a microchip-embedded pill connecting patients, caregivers and physicians to monitor adherence.
The supporting digital ecosystem - mobile application and HCP dashboard - had to be developed from scratch to support these goals. Otsuka stakeholders faced extreme pressure to develop and launch the entire solution and prove the business case and new technology while delivering ROI.
Over multiple years we guided Otsuka from a blank sheet to successful web and app launches and FDA approval of all digital assets, with our efforts already positively impacting lives